相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cell type-specific transcriptomics identifies neddylation as a novel therapeutic target in multiple sclerosis
Kicheol Kim et al.
BRAIN (2021)
Pyroptosis-Related Gene Signature Is a Novel Prognostic Biomarker for Sarcoma Patients
Dalong Wei et al.
DISEASE MARKERS (2021)
Establishment of A Nomogram for Predicting the Prognosis of Soft Tissue Sarcoma Based on Seven Glycolysis-Related Gene Risk Score
Yuhang Liu et al.
FRONTIERS IN GENETICS (2021)
Identification of Novel Prognostic Risk Signatures of Soft Tissue Sarcoma Based on Ferroptosis-Related Genes
Wenjing Huang et al.
FRONTIERS IN ONCOLOGY (2021)
TP53 mutations increase radioresistance in rhabdomyosarcoma and Ewing sarcoma
Dana L. Casey et al.
BRITISH JOURNAL OF CANCER (2021)
Tumor necroptosis is correlated with a favorable immune cell signature and programmed death-ligand 1 expression in cholangiocarcinoma
Thanpisit Lomphithak et al.
SCIENTIFIC REPORTS (2021)
Cell type-specific transcriptomics identifies neddylation as a novel therapeutic target in multiple sclerosis
Kicheol Kim et al.
BRAIN (2021)
Fructose-1,6-Bisphosphatase 2 Inhibits Sarcoma Progression by Restraining Mitochondrial Biogenesis
Peiwei Huangyang et al.
CELL METABOLISM (2020)
Structure-Mediated RNA Decay by UPF1 and G3BP1
Joseph W. Fischer et al.
MOLECULAR CELL (2020)
Development of a risk scoring system for evaluating the prognosis of patients with Her2-positive breast cancer
Chundi Gao et al.
CANCER CELL INTERNATIONAL (2020)
TIMER2.0 for analysis of tumor-infiltrating immune cells
Taiwen Li et al.
NUCLEIC ACIDS RESEARCH (2020)
A missense mutation in the MLKL brace region promotes lethal neonatal inflammation and hematopoietic dysfunction
Joanne M. Hildebrand et al.
NATURE COMMUNICATIONS (2020)
A hypoxia-related signature for clinically predicting diagnosis, prognosis and immune microenvironment of hepatocellular carcinoma patients
Baohui Zhang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy
Tuba N. Gide et al.
CANCER CELL (2019)
Autophagy, anoikis, ferroptosis, necroptosis, and endoplasmic reticulum stress: Potential applications in melanoma therapy
Milad Ashrafizadeh et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
The role of necroptosis in cancer biology and therapy
Yitao Gong et al.
MOLECULAR CANCER (2019)
TP53 in bone and soft tissue sarcomas
Elizabeth Thoenen et al.
PHARMACOLOGY & THERAPEUTICS (2019)
Immune Signature-Based Subtypes of Cervical Squamous Cell Carcinoma Tightly Associated with Human Papillomavirus Type 16 Expression, Molecular Features, and Clinical Outcome
Xiaofan Lu et al.
NEOPLASIA (2019)
Type I IFN operates pyroptosis and necroptosis during multidrug-resistant A. baumannii infection
Yang Li et al.
CELL DEATH AND DIFFERENTIATION (2018)
Necroptosis in development and diseases
Bing Shan et al.
GENES & DEVELOPMENT (2018)
Soft Tissue Sarcoma, Version 2.2018
Margaret von Mehren et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)
Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia
Michele Massimino et al.
MOLECULAR CANCER (2018)
Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications
Marion Gruffaz et al.
MBIO (2018)
The p55TNFR-IKK2-Ripk3 axis orchestrates arthritis by regulating death and inflammatory pathways in synovial fibroblasts
Marietta Armaka et al.
NATURE COMMUNICATIONS (2018)
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Peng Jiang et al.
NATURE MEDICINE (2018)
A phase II study of tivozanib in patients with metastatic and nonresectable soft-tissue sarcomas
M. Agulnik et al.
ANNALS OF ONCOLOGY (2017)
Necroptosis in development, inflammation and disease
Ricardo Weinlich et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas
Alexander J. Lazar et al.
CELL (2017)
Lysis of human neutrophils by community-associated methicillin-resistant Staphylococcus aureus
Mallary C. Greenlee-Wacker et al.
BLOOD (2017)
Phase II study of MLN8237 (Alisertib) in advanced/metastatic sarcomaaEuro
M. A. Dickson et al.
ANNALS OF ONCOLOGY (2016)
Cancer therapy in the necroptosis era
Z. Su et al.
CELL DEATH AND DIFFERENTIATION (2016)
Doxorubicin plus the IGF-1R antibody cixutumumab in soft tissue sarcoma: a phase I study using the TITE-CRM model
R. Chugh et al.
ANNALS OF ONCOLOGY (2015)
Aplidin in patients with advanced dedifferentiated liposarcomas: a French Sarcoma Group Single-Arm Phase II study
M. Toulmonde et al.
ANNALS OF ONCOLOGY (2015)
Combined Radiation Therapy and Sunitinib for Preoperative Treatment of Soft Tissue Sarcoma
Jens Jakob et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
A Novel Approach to High-Quality Postmortem Tissue Procurement: The GTEx Project
Latarsha J. Carithers et al.
BIOPRESERVATION AND BIOBANKING (2015)
PD-L1 checkpoint blockade prevents immune dysfunction and leukemia development in a mouse model of chronic lymphocytic leukemia
Fabienne McClanahan et al.
BLOOD (2015)
The Expression of HSPD1, SCUBE3, CXCL14 and Its Relations with the Prognosis in Osteosarcoma
Wenqing Liang et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2015)
Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeutics
Gi-Bang Koo et al.
CELL RESEARCH (2015)
Necroptosis and its role in inflammation
Manolis Pasparakis et al.
NATURE (2015)
Absence of RIPK3 predicts necroptosis resistance in malignant melanoma
P. Geserick et al.
CELL DEATH & DISEASE (2015)
A Novel Approach to High-Quality Postmortem Tissue Procurement: The GTEx Project
Latarsha J. Carithers et al.
BIOPRESERVATION AND BIOBANKING (2015)
Long-term responders and survivors on pazopanib for advanced soft tissue sarcomas: subanalysis of two European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62043 and 62072
B. Kasper et al.
ANNALS OF ONCOLOGY (2014)
Breast cancer patient stratification using a molecular regularized consensus clustering method
Chao Wang et al.
METHODS (2014)
Necroptosis
Andreas Linkermann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Necroptosis in health and diseases
Wen Zhou et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2014)
Critical limitations of consensus clustering in class discovery
Yasin Senbabaoglu et al.
SCIENTIFIC REPORTS (2014)
Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines
Paul Geeleher et al.
GENOME BIOLOGY (2014)
SCUBE3 regulation of early lung cancer angiogenesis and metastatic progression
Cheng-Hung Chou et al.
CLINICAL & EXPERIMENTAL METASTASIS (2013)
Trabectedin in the treatment of metastatic soft tissue sarcoma: cost-effectiveness, cost-utility and value of information
E. J. O. Soini et al.
ANNALS OF ONCOLOGY (2011)
Pazopanib: Clinical development of a potent anti-angiogenic drug
Fabio A. B. Schutz et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2011)
ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking
Matthew D. Wilkerson et al.
BIOINFORMATICS (2010)
Necroptosis as an alternative form of programmed cell death
Dana E. Christofferson et al.
CURRENT OPINION IN CELL BIOLOGY (2010)
Molecular mechanisms of necroptosis: an ordered cellular explosion
Peter Vandenabeele et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Immune infiltration in human tumors: a prognostic factor that should not be ignored
F. Pages et al.
ONCOGENE (2010)
Receptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-α
Sudan He et al.
CELL (2009)
RIP3, an Energy Metabolism Regulator That Switches TNF-Induced Cell Death from Apoptosis to Necrosis
Duan-Wu Zhang et al.
SCIENCE (2009)
Necroptosis: A Specialized Pathway of Programmed Necrosis
Lorenzo Galluzzi et al.
CELL (2008)
Bortezomib-mediated proteasome inhibition as a potential strategy for the treatment of rhabdomyosarcoma
Francesca Bersani et al.
EUROPEAN JOURNAL OF CANCER (2008)
分享论文
